# Four-Dimensional Computed Tomography of Respiratory Function Changes Post-Radiotherapy for Lung Cancer

**Authors:** Shiho Wada, Tomohiro Itonaga, Ryuji Mikami, Tatsuhiko Zama, Yukinori Okada, Kazuhiro Saito

PMC · DOI: 10.7759/cureus.103971 · Cureus · 2026-02-20

## TL;DR

This case report explores how lung function changes over time after radiotherapy for lung cancer using advanced imaging techniques.

## Contribution

The study introduces the use of 4DCT ventilation imaging to track functional lung changes post-radiotherapy in a single patient.

## Key findings

- Highly irradiated lung regions showed progressive volume reduction over time.
- Non-irradiated lung regions increased in volume slightly.
- Ventilation decline persisted in low-dose regions, suggesting long-term functional impact.

## Abstract

Radiotherapy (RT) plays an important role in the curative treatment of lung cancer; however, longitudinal changes in regional pulmonary function after treatment remain incompletely understood. In this case report, we present a single-patient, hypothesis-generating analysis evaluating the association between lung dose and regional functional changes using deformable image registration (DIR)-based four-dimensional computed tomography (4DCT) ventilation imaging (Jacobian-derived) obtained at three time points: pre-RT, six months post-RT, and one year post-RT. An 83-year-old male with clinical stage IIIA right upper lobe lung cancer underwent definitive chemoradiotherapy. Consolidation durvalumab was initiated post-treatment, and the patient developed pneumonitis consistent with radiation-induced lung injury (Common Terminology Criteria for Adverse Events (CTCAE) grade 2), which was managed with oral prednisolone. SpO₂ was 94% on room air, and oxygen therapy was not required. Dynamic analysis of 4DCT images showed that the volume of the highly irradiated right upper lobe decreased over time, while the rate of contraction increased. The volume of the non-irradiated left lower lobe increased by 11% at one year post-RT, whereas the rate of contraction decreased slightly. 4DCT-derived ventilation suggested a dose-related decline in ventilation that persisted at one year, including within low-dose regions. This single-case observation supports the potential value of integrating functional information with anatomic CT findings during post-RT follow-up and in efforts to preserve functional lung, while acknowledging the limitations related to a single patient, DIR-dependent ventilation estimates, and the absence of post-treatment pulmonary function testing.

## Linked entities

- **Chemicals:** prednisolone (PubChem CID 5755)
- **Diseases:** lung cancer (MONDO:0005138), pneumonitis (MONDO:0043905)

## Full-text entities

- **Diseases:** NSCLC (MESH:D002289), PFTs (OMIM:608852), COPD (MESH:D029424), pneumonitis (MESH:D011014), dyspnea (MESH:D004417), Lung Cancer (MESH:D008175), ICI (MESH:D054179), tumor (MESH:D009369), adenocarcinoma (MESH:D000230), RP (MESH:D017564), RILI (MESH:D055370), inflammation (MESH:D007249), fibrosis (MESH:D005355), hypoventilation (MESH:D007040), stage III (MESH:D062706), interstitial lung disease (MESH:D017563), radiation-induced (MESH:D009381), hypertrophy (MESH:D006984), metastases (MESH:D009362)
- **Chemicals:** S6 (MESH:C012008), paclitaxel (MESH:D017239), oxygen (MESH:D010100), steroids (MESH:D013256), Durvalumab (MESH:C000613593), 18-Fluorine fludeoxyglucose (-), Prednisolone (MESH:D011239), carboplatin (MESH:D016190)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922633/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922633/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922633/full.md

---
Source: https://tomesphere.com/paper/PMC12922633